Lily is Senior research fellow in Health economics and mathematical modeller.
Lily have rich experience in economic evaluation alongside large clinical trials and HTA reviews, well developed knowledge of statistical methodology, and excellent computational skills with respect to statistical analysis and modelling in economic evaluation. She has successfully secured several grants as co-applicant including NIHR HTA funded projects, DoH policy program, and as principle investigator on several consultant works through NICE, academic institutes and industries. She has published widely in leading scientific journals including BMJ, European Heart Journal. Lily has been awarded several scholarships in the past including a Sino-British Friendship Scholarship Scheme.
Senior research fellow in health economics
PhD in Health Economics, University of Birmingham
MSc in Economics of Public Policy, University of Hull
BSc in Pure Mathematics, University of Zhongshan, China
Lily is interested in supervising doctoral research students in the following areas:
Economic evaluation alongside clinical trial
Mathematical modelling in health care management
If you are interesting in studying any of these subject areas please contact Lily on the contact details above, or for any general doctoral research enquiries, please email: email@example.com or call +44 (0)121 414 5005.
For a full list of available Doctoral Research opportunities, please visit our Doctoral Research programme listings.
Economic evaluation alongside clinical trial
Health technology assessment (HTA)
Mathematical modelling in health service delivery
Lily Yao is currently working on MATCH project and CLAHRC. In addition, she has led on the economic section on several projects in which she has co-investigator.
1. External Assessment Centre to support the Evaluation Pathway Programme, funded by NICE £1.9m. Agreed and in process to contract. Lily co-leads (/co-PI) on this application
2. A cluster randomised controlled trial of an occupational therapy intervention for residents with stroke living in UK care-homes (OTCH). This project is funded by NIHR HTA. Lily Yao is a co-applicant and leads and supervises the research fellow on health economic section. Total grant £1.9 m Duration 2009 - 2013
3. A systematic review and observational study of the epidemiology and natural history of progressive neurological disease, targeting user priorities and modelling the impact on care services (LTNC). Total grant £390,190. NIHR Policy Programme. Lily Yao is a co-applicant and leads and co-supervises the research fellow on health economic study. Total grant £ 390,190. Duration 2008 to 2010 (drawing conclusion in Feb 2011).
4. Randomised controlled trial to assess the clinical- and cost-effectiveness of physiotherapy and occupational therapy in Parkinson's disease (PD REHAB). The project is funded by NIHR HTA. Lily Yao is a co-investigator and leads and supervises the research fellow on health economic section. Duration 2008 – 2013
5. CT colonography, colonoscopy or barium enema for diagnosis of colorectal cancer in order symptomatic patients: SIGGAR1. This is funded by NIHR HTA and led by Steve Halligan, Imperial College. Sub-contracted with Imperial College in which Lily leads on the economic evaluation and supervise the research fellow. Total grant £58,000. June 2010 to July 2011
Completed HTA Reports
1. Immunosuppressive therapy for renal transplantation in children. (Yao, et al HTA 2006)
2. The clinical effectiveness and cost effectiveness of immuno-suppressive therapy for renal transplantation (adults), (Woodroffe, Yao, et al. HTA 2005)
3. Cost - effectiveness analysis of Anaemia (chemotherapy-induced): erythropoetin (alpha and beta) and darbepoetin. (Wilson, Yao et al. HTA 2007)
4. Imatinib mesylate for the treatment of patients with gastro-intestinal stromal tumours (GIST). (Wilson, Connock, Song, Yao et al HTA 2005)
5. Screening for fragile x syndrome (Song, Barton, Sleightholme, Yao et al. HTA 2003)
Completed projects on economic evaluations alongside phase III clinical trials
1. Nurse led secondary prevention clinics (Raftery and Yao BMJ 2005)
2. Cardiac resynchronisation devices in patient with health failure (Yao et al 2007, and Calvert, Fremantle and Yao European Heart Journal 2006)
3. Nebivolol treatment in eldly patient with heart failure (Yao 2008 Pharmcoeconomics)
4. A brief pain management programme and physical treatments for low back pain (Whitehurst, Lewis, Yao, et al. Arthritis Care & Research).
Thomas Hoppitt, Hardev Pall, Mel Calvert, Paramjit Gill, Guiqing Yao, Jill Ramsay, Gill James, Jacky Conduit, Cath Sackley, A Systematic Review of the Incidence and Prevalence of Long-Term Neurological Conditions in the UK. Neuroepidemiology 2011;36:19-28
Guiqing Yao, Nick Freemantle, Flather Marcus, Puvan Tharmanathan, Andrew Coats and Philip A. Poole-Wilson. Long-Term Cost-effectiveness Analysis of Nebivolol Compared With Placebo In Elderly Patients With Heart Failure – An Individual Patient based Simulation Model – Pharmacoeconomics. 2008;26(10):879-889.
Alec Miners, Guiqing Yao, James Raftery, Rod Taylor. Calcineurin Inhibitors in Renal Transplantation: A Review of Their Cost Effectiveness. 1. Pharmacoeconomics. 2007;25(11):935-47
Guiqing Yao, Nick Freemantle, Melanie J. Calvert, Stirling Bryan,a Jean Claude, Daubert John G.F. Cleland. The Long-term Cost-Effectiveness of Cardiac Resynchronization Therapy with or Without an Implantable Cardioverter-Defibrillator. European Heart Journal 2007 28: 42-51.
Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.
DGT Whitehurst, M Lewis, GL Yao, S Bryan, JP Raftery, R Mullis, EM Hay. A brief pain management programme and physical treatments for low back pain: results from an economic analysis alongside a randomised. Arthritis Care & Research 2007, Volume 57, Issue 3 , Pages 466 – 473.
Guiqing Yao, Esther Albon, Adi, Y, David Milford, Sue Bayliss, Andrew Ready, James Raftery, and Rod Taylor. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.. Health Technology Assessment. 2006 Dec;10 (49):1-178.
James P Raftery, Guiqing L Yao, Peter Murchie, Neil C Campbell, Lewis D Ritchie. The cost effectiveness of nurse-led secondary prevention clinics for coronary heart disease in primary care: four- year follow up of a randomised trial. British Medical Journal, Mar 2005; 330: 707